Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 4.80% is 26% below its 5-year average of 6.49%, near the low end of its 5-year range (0.00%–41.08%).
As of the fiscal period ended Wednesday, December 31, 2025. 68.90% below its 12-month average of 15.44%.
Reported quarterly debt to assets ratio; no daily interpolation. Q4 FY2025 (2025-12-31): 4.80%.
DEBT TO ASSETS RATIO
4.80%
DEBT TO ASSETS RATIO AVG TTM
15.44%
DEBT TO ASSETS RATIO AVG 3Y
6.84%
DEBT TO ASSETS RATIO AVG 5Y
6.49%
DEBT TO ASSETS RATIO AVG 10Y
9.22%
DEBT TO ASSETS RATIO AVG 15Y
0.53%
DEBT TO ASSETS RATIO AVG 20Y
5.05%
CURRENT VS TTM AVG
-68.90%
CURRENT VS 3Y AVG
-29.78%
CURRENT VS 5Y AVG
-26.04%
CURRENT VS 10Y AVG
-47.92%
CURRENT VS 15Y AVG
+806.31%
CURRENT VS 20Y AVG
-4.84%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+5235.43%
vs the sector median at left
SciSparc Ltd.
Market Cap
$250443.00
Debt to Assets Ratio
4.80%
TTM Avg
15.44%
3Y Avg
6.84%
5Y Avg
6.49%
Market Cap
$378849.00
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$110112.00
Debt to Assets Ratio
0.33%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$403887.00
Debt to Assets Ratio
0.18%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$95475.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$70884.00
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$29771.00
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SciSparc Ltd. (SPRC) | $250443.00 | 4.80% | 15.44% | 6.84% | 6.49% |
| Virax Biolabs Group Limited (VRAX)vs › | $378849.00 | 0.05% | N/A | N/A | N/A |
| Silexion Therapeutics Ltd. (SLXN)vs › | $110112.00 | 0.33% | N/A | N/A | N/A |
| Niki BioSolutions, Inc. (NIKI)vs › | $403887.00 | 0.18% | N/A | N/A | N/A |
| Psyence Biomedical Ltd. (PBM)vs › | $95475.00 | 0.00% | N/A | N/A | N/A |
| PRF Technologies Ltd. (PRFX)vs › | $70884.00 | 0.00% | N/A | N/A | N/A |
| Akanda Corp. (AKAN)vs › | $61172.00 | 2.89% | N/A | N/A | N/A |
| Zhongchao Inc. (ZCMD)vs › | $30389.00 | 0.00% | N/A | N/A | N/A |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $29771.00 | 0.01% | N/A | N/A | N/A |
| XORTX Therapeutics Inc. (XRTX)vs › | $481786.00 | 0.00% | N/A | N/A | N/A |
Debt/Assets
4.8%
Debt/Equity
0.09
Current Ratio
2.41
Interest Coverage
-795.4x
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2025-12-31 | 4.80% |
| 2025-06-30 | 41.08% |
| 2024-12-31 | 0.44% |
| 2024-06-30 | 0.61% |
| 2023-12-31 | 0.68% |
| 2023-06-30 | 0.00% |
| 2022-12-31 | 0.25% |
| 2022-06-30 | 0.31% |
| 2021-12-31 | 5.08% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 18.16% |
| 2020-06-30 | 29.13% |
| 2019-12-31 | 43.33% |
| 2019-06-30 | 56.34% |
| 2018-12-31 | 40.53% |
| 2018-06-30 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-06-30 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-06-30 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2011-12-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2009-12-31 | 12.12% |
| 2008-12-31 | 14.80% |
| 2007-12-31 | 26.61% |
| 2006-12-31 | 33.34% |
